This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

ThermoGenesis Announces New Cord Blood Products Distribution Agreements

RANCHO CORDOVA, Calif., Sept. 19, 2012 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing, storage and administration of cell therapies, today said it has signed two additional new channel partner agreements as part of its continuing program to enhance its distribution, technical service and clinical support initiatives of its cord blood products.

Under a new agreement with HVD Biotech Vertriebs GmbH ("HVD"), HVD will have exclusive distribution rights for the AXP ® AutoXpress ® System and BioArchive ® System in 10 European countries—including Germany, Austria, and the Czech Republic—and 13 Middle Eastern countries, including Egypt, Saudi Arabia and the United Arab Emirates.

The Company also announced an expanded distribution agreement with Comércio Exportação e Importação de Materiais Médicos Ltda ("CEI"), under which CEI will have exclusive distribution rights for the AXP and BioArchive in nine Latin American countries, including Mexico, Brazil, and Argentina. CEI has been distributing the BioArchive System and ThermoGenesis manual cord blood processing and storage sets for cryopreservation of 25mL concentrated samples in Latin American countries since 2000.

"These new integrated agreements, combined with our recently announced distribution agreement in other European markets with Concessus are important milestones in our strategy to provide a customer-centric focus that incorporates sales, service and support for our cord blood product portfolio. We believe these new partners will further both our existing customer relationships and market expansion efforts for our best-in-class offerings," said Hal Baker, Vice President of Commercial Operations for ThermoGenesis.

"We look forward to working with ThermoGenesis on further developing these important European and Middle Eastern markets. We believe there are significant opportunities with cord blood banks in these regions and that ThermoGenesis' offerings provide important competitive advantages," said Hermanus van Duyne, Managing Director of HVD.

"We have had a very positive experience with ThermoGenesis over the past 12 years and are excited about the new market opportunities under our expanded relationship with the Company," said Paulo Pacheco, Chief Executive Officer of CEI.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs